Causes: deposition of amyloid material in the cerebral cortex lead to cell
death. Incidence: 1% above 60 years, 40% above 85 years, 10% of the cases occurs in population below 60 years. C/P: all clinical picture due to decrease acetyl choline!, Duration: from start the disease to reach sta"e # is 8$15 years Sages: A) Stage 1: in which there is 1) Memory: loss of memory start with recent memory and extend "radually to the past memory.to ta%e all memory! 2) Mood changes: depression, in ability to do wor%, and loss of words 3) eha!ioural changes: disorientation for time ") &isturbance of sleep rhythm #) 'sychotic symptoms ) Stage 2: in which there is 1! (ncrease of the symptoms of sta"e 1 )! *eurolo"ical symptoms #! +xtrapyramidal symptoms C) Stage 3: 1! (ncrease of the symptoms of sta"e ) )! ,e"etative state #! (ncrease memory a-ection 4! (ncontinence for both faecal and urine mainly if patient above 65 years, inability to dress alone 5! &on.t remember any one 6! /inally death may occur $rt: li%e dementia treatment 1! *o speci0c mana"ement )! 1ive treatment to delay pro"ression of memory loss as choline esterase inhibitors which act by increase acetyl choline as rivasti"mine exelon! 1.5 m" tab 1$# tab2day. #! Sym%tomatic treatment: a) &or 'eha!iour distur'ance: haloperidol 5 m"2day or risperidone 1 m"2day ') &or mood distur'ance: antidepressant 334(! c) &or slee% distur'ance: ben5odia5epine 0.)5 m" at bed time.